Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;59(6):371-6.
doi: 10.4097/kjae.2010.59.6.371. Epub 2010 Dec 31.

Interactions of propofol and remifentanil on bispectral index under 66% N(2)O: analysis by dose-effect curve, isobologram, and combination index

Affiliations

Interactions of propofol and remifentanil on bispectral index under 66% N(2)O: analysis by dose-effect curve, isobologram, and combination index

Won Ho Kim et al. Korean J Anesthesiol. 2010 Dec.

Abstract

Background: Propofol and remifentanil are usually co-administered and have shown synergistic effect for anesthesia. However, the synergistic effect of the two drugs on hypnosis measured by bispectral index (BIS) was controversial in previous studies. The aim of this study was to identify the interaction of propofol and remifentanil on BIS and the optimal dose combinations for hypnosis under 66% N(2)O during surgery.

Methods: Patients (age 55-75 and American Society of Anesthesiologists [ASA] 1-2) undergoing gastrectomy were enrolled in this study. Propofol and remifentanil were co-administered incrementally at 1 : 1 potent ratio (the P1R1 group), at 1 : 2 potent ratio (the P1R2 group), or at 2 : 1 potent ratio (the P2R1 group) using effect site target-controlled infusion and BIS was measured. 66% N(2)O was concomitantly administered to all groups. The dose-effect curves, the 90% effective dose (EC(90)) for adequate hypnosis (BIS 40), isobolograms and combination index were obtained by Calcusyn program (Biosoft) to reveal the interaction of propofol and remifentanil.

Results: The P2R1 group showed synergistic action on BIS. However, the other groups needed larger amount of each drug than the doses of additive action. The EC(90) of the P2R1 group was propofol, 3.34 µg/ml and remifentanil, 2.41 ng/ml under 66% of N(2)O.

Conclusions: Propofol dominant co-administration is needed for dose reduction in BIS guided hypnosis.

Keywords: Bispectral index; Isobologram; Propofol; Remifentanil; Synergies.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Hemodynamic changes. *p < 0.05 compared to 15, 30, 45, 60 minutes in the P1R2 group. p < 0.05 between the P1R2 and P2R1 group. P1R2: propofol : remifentanil 1 : 2 potency, P2R1: propofol : remifentanil 2 : 1 potency.
Fig. 2
Fig. 2
The dose-effect curve of propofol of the P1R1, P1R2, and P2R1 groups. The effect site concentration of propofol in the P1R1, P1R2, and P2R1 groups and the hypnotic effect are shown as the X and Y axes, respectively. The P2R1 group required the lowest effect site concentration of propofol for EC90. P1R1: propofol : remifentanil 1 : 1 potency, P1R2: propofol : remifentanil 1 : 2 potency, P2R1: propofol : remifentanil 2 : 1 potency, EC90: 90% effective dose.
Fig. 3
Fig. 3
The dose-effect curve of remifentanil of the P1R1, P1R2, and P2R1 groups. The effect site concentration of remifentanil in the P1R1, P1R2, and P2R1 groups and the hypnotic effect are shown as the X and Y axes, respectively. The P2R1 group required the lowest effect site concentration of remifentanil for EC90. P1R1: propofol : remifentanil 1 : 1 potency, P1R2: propofol : remifentanil 1 : 2 potency, P2R1: propofol : remifentanil 2 : 1 potency, EC90: 90% effective dose.
Fig. 4
Fig. 4
Isobologram. The EC90 for single administration were placed on the X- and Y-axes with the 95% confidence limits. The dashed lines connecting both EC90 represents the theoretical line of additivity. The ⊙ in the middle of the graph depict the experimentally derived EC90 in each group with the 95% confidence limits as error bars. The isobologram shows the synergistic interaction in the P2R1 group, and the antagonistic interaction in the P1R1 and P1R2 groups at EC90. EC90: 90% effective dose, P2R1: propofol : remifentanil 2 : 1 potency, P1R1: propofol : remifentanil 1 : 1 potency, P1R2: propofol : remifentanil 1 : 2 potency.

Similar articles

Cited by

References

    1. Mertens MJ, Olofsen E, Engbers FH, Burm AG, Bovill JG, Vuyk J. Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil-propofol interactions. Anesthesiology. 2003;99:347–359. - PubMed
    1. Mustola ST, Baer GA, Neuvonen PJ, Toivonen KJ. Requirements of propofol at different end-points without adjuvant and during two different steady infusions of remifentanil. Acta Anaesthesiol Scand. 2005;49:215–221. - PubMed
    1. Strachan AN, Edwards ND. Randomized placebo-controlled trial to assess the effect of remifentanil and propofol on bispectral index and sedation. Br J Anaesth. 2000;84:489–490. - PubMed
    1. Koitabashi T, Johansen JW, Sebel PS. Remifentanil dose/electroencephalogram bispectral response during combined propofol/regional anesthesia. Anesth Analg. 2002;94:1530–1533. - PubMed
    1. Röpcke H, Könen-Bergmann M, Cuhls M, Bouillon T, Hoeft A. Propofol and remifentanil pharmacodynamic interaction during orthopedic surgical procedures as measured by effects on bispectral index. J Clin Anesth. 2001;13:198–207. - PubMed

LinkOut - more resources